HAEMONETICS CORP MASS shareholders Q2 2023

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 54 filers reported holding HAEMONETICS CORP MASS in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

HAEMONETICS CORP MASS shareholders Q2 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 17,558$15,0281.36%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,406,1541.02%
ADVENT CAPITAL MANAGEMENT /DE/ 53,348,000$45,660,4170.88%
DeepCurrents Investment Group LLC 24,371,000$20,841,7960.82%
MACKAY SHIELDS LLC 29,499,000$25,204,7360.70%
SSI INVESTMENT MANAGEMENT LLC 11,208,000$9,536,8590.67%
Aequim Alternative Investments LP 20,500,000$17,545,8980.66%
Quaero Capital S.A. 900,000$769,6350.59%
READYSTATE ASSET MANAGEMENT LP 8,000,000$6,847,1800.52%
Empyrean Capital Partners, LP 12,000,000$10,215,0000.46%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,010,000$859,4060.42%
WOLVERINE ASSET MANAGEMENT LLC 39,207,000$33,498,1510.40%
Wellesley Asset Management 5,263,648$4,673,4130.38%
LINDEN ADVISORS LP 40,483,000$34,631,6700.36%
OAKTREE CAPITAL MANAGEMENT LP 26,145,000$22,377,4390.30%
Verition Fund Management LLC 15,292$13,088,3840.18%
AVIVA PLC 30,000,000$25,588,2300.10%
Shaolin Capital Management LLC 2,000,000$1,7130.06%
Leucadia National 6,807,000$5,825,3420.05%
BEACON INVESTMENT ADVISORS LLC 64,000$54,4580.04%

This page lists HAEMONETICS CORP MASS's shareholders in Q2 2023. To view HAEMONETICS CORP MASS's shareholder history, click here.